What Fueled The Previous Growth In The Lab Automation In Genomics Market?
The lab automation in genomics market has seen considerable growth due to a variety of factors.
• The market size of lab automation in genomics has experienced substantial expansion in the past few years. The growth is projected to continue from $2.33 billion in 2024 to $2.7 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%.
The rise during the past years can be credited to increasing demand for accuracy in medicine, the growing complexity of genomic data, a sharper focus on genomic research, larger utilization in clinical diagnostics, as well as the need for scalability and flexibility.
What Is The Expected Growth In The Lab Automation In Genomics Market Size Evolve over the Forecast Period?
The lab automation in genomics market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for lab automation in genomics is anticipated to witness considerable growth in the forthcoming years, expanding to $4.82 billion in 2029 with a compound annual growth rate (CAGR) of 15.6%.
The growth in this predicted timeline can be due to the proliferation of point-of-care testing, the shift towards cloud-based solutions, the emphasis on real-time and continuous monitoring, the burgeoning of precision agriculture, and the rise in multi-omics integration. The forecast period is also expected to see major trends such as the adoption of automated instruments, the implementation of lab automation systems, automated technologies, and cloud-based platforms.
What Main Forces Are Fueling Expansion In The Lab Automation In Genomics Market?
The increasing acceptance of precision medicine is anticipated to stimulate the growth of lab automation within the genomics market in the future. Precision medicine offers a bespoke approach to healthcare, taking into account individual variations in genes, lifestyle, and environment in order to provide tailored medical treatments. The call for precision medicine is growing due to factors like genomics advancements, targeted treatments, patient-centric care, and progress in drug development. Precision medicine requires a multitude of genetic tests to identify disease-related genes. This compels labs to efficiently and accurately process a large volume of samples, leading to the utilization of automated systems. For instance, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported in February 2024 that the FDA had approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from just six in 2022. Thus, the rising acceptance of precision medicine is pushing the growth of lab automation in the genomics market.
What Are The Primary Segments In The Global Lab Automation In Genomics Market?
The lab automation in genomics market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Process: Continuous Automation System, Modular Automation System
3) By Application: Hospitals And Private Labs, Biotech And Pharma, Academics And Research Institutes, Other Applications
Subsegments:
1) By Automated Liquid Handlers: Liquid Transfer Systems, Pipetting Robots
2) By Automated Plate Handlers: Plate Stacker Systems, Microplate Transport Systems
3) By Robotic Arms: Single-Axis Robotic Arms, Multi-Axis Robotic Arms
4) By Automated Storage And Retrieval Systems: Sample Storage Systems, Automated Retrieval Systems
5) By Other Types: Nucleic Acid Extraction Systems, Other Custom Automation Solutions
Pre-Book The Lab Automation In Genomics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Lab Automation In Genomics Market?
Key players in the genomics market for lab automation are concentrating on the creation of advanced solutions like automated whole genome sequencing (WGS) to make significant strides in genomics research, clinical diagnostics, and precision medicine. Automated WGS involves the use of high-throughput, automated sequencing technologies to sequence an individual's genome. For example, in May 2023, Clear Labs, Inc., a US company that specializes in genomics testing, introduced Clear Dx. This innovative solution delivers complete automation of sample processing, assuring exact and consistent library preparation and management for genomics. Clear Dx's automation reduces human discrepancy and ensures consistency in sequencing, resulting in dependable and repeatable results. It simplifies the process of genome sequencing, reducing manual intervention to merely 30 minutes with a single touchpoint, making easy whole genome sequencing a possibility even without specialized training.
Who Are the Key Players In The Lab Automation In Genomics Market?
Major companies operating in the lab automation in genomics market report are:
• Pfizer Inc.
• Robert Bosch GmbH
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Danaher Corporation
• Becton
• Dickinson and Company
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Tecan Group Ltd.
• Illumina Inc.
• Hamilton Company
• Promega Corporation
• Oxford Nanopore Technologies Ltd.
• Fluidigm Corporation
• Gilson Incorporated
What Is The Most Dominant Region In The Lab Automation In Genomics Market?
North America was the largest region in the lab automation in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
